Tego Science Inc
191420
Company Profile
Business description
Tego Science Inc is a biotech company that researches and develops regenerative medicine. It is engaged in the production of epidermis and cornea wound healing solution. Its products include Holoderm, SkinBank, Kaloderm, and Neoderm. It also provides testing services.
Contact
93, Magokjungang 8-ro
Gangseo-gu
Seoul
KORT: +82 28182900
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
42
Stocks News & Analysis
stocks
Weekly earnings wrap: Last week’s winners & losers
A mixed first week for company’s reporting on the ASX. Here’s everything you need to know
stocks
Alphabet earnings: Continued momentum on cloud and search as capital expenses set to mount
Strong fourth quarter earnings.
stocks
Eli Lilly earnings: Revenue increases reflect global demand for oral obesity therapies
We’ve raised our fair value estimate of Lilly stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,979.90 | 78.90 | -0.87% |
| CAC 40 | 8,238.17 | 23.99 | -0.29% |
| DAX 40 | 24,491.06 | 111.98 | -0.46% |
| Dow JONES (US) | 48,908.72 | 592.58 | -1.20% |
| FTSE 100 | 10,309.22 | 93.12 | -0.90% |
| HKSE | 26,456.53 | 428.71 | -1.59% |
| NASDAQ | 22,540.59 | 363.99 | -1.59% |
| Nikkei 225 | 53,984.74 | 166.70 | 0.31% |
| NZX 50 Index | 13,444.02 | 23.27 | -0.17% |
| S&P 500 | 6,798.40 | 84.32 | -1.23% |
| S&P/ASX 200 | 8,734.30 | 71.20 | -0.81% |
| SSE Composite Index | 4,073.75 | 2.16 | -0.05% |